References
- Hodi F, O’Day S, McDermott D, Weber R, Sosman J, Haanen J, Gonzalez R, Roberts C, Schadendorf D, Hassel J, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 2010; 363:711-23; PMID:20525992; http://dx.doi.org/10.1056/NEJMoa1003466
- Prieto PA, Yang JC, Sherry RM, Hughes MS, Kammula US, White DE, Levy CL, Rosenberg SA, Phan GQ. CTLA-4 blockade with ipilimumab: long-term follow-up of 177 patients with metastatic melanoma. Clin Cancer Res 2012; 18:2039-47; PMID:22271879; http://dx.doi.org/10.1158/1078-0432.CCR-11-1823
- Eckert A, Schoeffler A, Dalle S, Phan A, Kiakouama L, Thomas L. Anti-CTLA4 monoclonal antibody induced sarcoidosis in a metastatic melanoma patient. Dermatology 2009; 218:69-70; PMID:18832811; http://dx.doi.org/10.1159/000161122
- Berthod G, Lazor R, Letovanec I, Romano E, Noirez L, Stalder J, Speiser D, Peters S, Michielin O. Pulmonary sarcoid-like granulomatosis induced by ipilimumab. J Clin Oncol 2012; 30:10-3; PMID:22547608; http://dx.doi.org/10.1200/JCO.2011.39.3298
- Vogel W, Guislain A, Kvistborg P, Schumacher T, Haanen J, Blank C. Ipilimumab-induced sarcoidosis in a patient with metastatic melanoma undergoing complete remission. J Clin Oncol 2012; 30:7-10; PMID:22124098; http://dx.doi.org/10.1200/JCO.2011.37.9693
- Wilgenhof S, Morlion V, Seghers AC, Du Four S, Vanderlinden E, Hanon S, Vandenbroucke F, Everaert H, Neyns B. Sarcoidosis in a patient with metastatic melanoma sequentially treated with anti-CTLA-4 monoclonal antibody and selective BRAF inhibitor. Anticancer Res 2012; 32:1355-9; PMID:22493370
- Reule RB, North JP. Cutaneous and pulmonary sarcoidosis-like reaction associated with ipilimumab. J Am Acad Dermatol 2013; 69:e272-3; PMID:24124863; http://dx.doi.org/10.1016/j.jaad.2013.07.028
- Tissot C, Carsin A, Freymond N, Pacheco Y, Devouassoux G. Sarcoidosis complicating anti-cytotoxic T-lymphocyte-associated antigen-4 monoclonal antibody biotherapy. Eur Respir J 2013; 41:246-7; PMID:23277525; http://dx.doi.org/10.1183/090319-36.00107912
- Baughman RP, Lower EE, du Bois RM. Sarcoidosis. Lancet 2003; 361:1111-8; PMID:12672326; http://dx.doi.org/10.1016/S0140-6736(03)12888-7
- Iannuzzi M, Fontana J. Sarcoidosis: clinical presentation, immunopathogenesis, and therapeutics. Jama 2011; 305:391-9; PMID:21266686; http://dx.doi.org/10.1001/jama.2011.10
- Rosen Y. Pathology of sarcoidosis. Semin Respir Crit Care Med 2007; 28:36-52; PMID:17330191; http://dx.doi.org/10.1055/s-2007-970332
- Seve P, Schott AM, Pavic M, Broussolle C, Gilis L, Thomas L. Sarcoidosis and melanoma: a referral center study of 1,199 cases. Dermatology 2009; 219:25-31; PMID:19365109; http://dx.doi.org/10.1159/000213245
- Zia H, Zemon H, Brody F. Laparoscopic splenectomy for isolated sarcoidosis of the spleen. J Laparoendosc Adv Surg Tech 2005; 15:160-2; PMID:15898908; http://dx.doi.org/10.1089/lap.2005.15.160
- Chen M-Y, Cai J-T, Du Q, Wang L-J. Sarcoidosis of spleen presenting with solitary thrombopenia. Eur J Intern Med 2009; 20:e12; PMID:19237065; http://dx.doi.org/10.1016/j.ejim.2007.09.022
- Mohan A, Sood R, Shariff N, Gulati MS, Gupta SD, Dutta AK. Sarcoidosis manifesting as massive splenomegaly: a rare occurrence. Am J Med Sci 2004; 328:170-2; PMID:15367876; http://dx.doi.org/10.1097/00000441-200409000-00007